Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Femasys (FEMY)
NASDAQ:FEMY
Femasys (FEMY) Stock Price & Analysis
276 Followers
FEMY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $4.75
Previous Close$1.42
Volume306.17K
Average Volume (3M)637.99K
Market Cap
$31.55M
Enterprise Value$20.85M
Total Cash (Recent Filing)$10.71M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-1.5
Beta-0.19
Next Earnings
May 09, 2024EPS Estimate
-$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.94
Shares Outstanding22,099,347
10 Day Avg. Volume128,192
30 Day Avg. Volume637,989
Standard Deviation1.05
R-Squared0.02
Alpha0.12
Financial Highlights & Ratios
Price to Book (P/B)2.86
Price to Sales (P/S)26.02
Price to Cash Flow (P/CF)-2.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue17.43
Enterprise Value/Gross Profit27.28
Enterprise Value/Ebitda-2.44
Forecast
1Y Price Target
$9.00Price Target Upside547.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Femasys News
Bulls Say, Bears Say
Bulls Say
Financial SupportFemasys announced a strategic upfront investment lead by PharmaCyte for $6.85M upfront, which combined with potential revenue from warrants, now expects Femasys has cash runway into 2H25.
Market OpportunityManagement has commented that infertility is a well-defined market, with approximately 430 practices in the US, many of which are already call points for Femasys' other devices.
Product LaunchFemaSeed US launch expected in early 2024 with no additional regulatory/manufacturing hurdles, and the launch will likely boost sales of all devices.
Bears Say
EarningsFemasys faces a challenging financial scenario with its recent quarterly report showing revenue of $244.4k juxtaposed with a substantial net loss of $4.0M.
Financial HealthConcerns about Femasys's liquidity are on the rise as cash and equivalents have seen a significant decrease since the end of the last fiscal year.
Product LaunchUncertainty surrounds the market debut of Femasys's new products, with the launch heavily reliant on the company's diminishing cash reserves.
---
Ownership Overview
8.00%
Insiders
1.94% Mutual Funds
2.55% Other Institutional Investors
87.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
FEMY FAQ
What was Femasys’s price range in the past 12 months?
Femasys lowest stock price was $0.25 and its highest was $4.75 in the past 12 months.
What is Femasys’s market cap?
Currently, no data Available
When is Femasys’s upcoming earnings report date?
Femasys’s upcoming earnings report date is May 09, 2024 which is today.
How were Femasys’s earnings last quarter?
Femasys released its earnings results on Mar 28, 2024. The company reported -$0.2 earnings per share for the quarter, beating the consensus estimate of -$0.212 by $0.012.
Is Femasys overvalued?
According to Wall Street analysts Femasys’s price is currently Undervalued.
Does Femasys pay dividends?
Femasys does not currently pay dividends.
What is Femasys’s EPS estimate?
Femasys’s EPS estimate is -$0.19.
How many shares outstanding does Femasys have?
Femasys has 22,220,718 shares outstanding.
What happened to Femasys’s price movement after its last earnings report?
Femasys reported an EPS of -$0.2 in its last earnings report, beating expectations of -$0.212. Following the earnings report the stock price went up 10.968%.
Which hedge fund is a major shareholder of Femasys?
Currently, no hedge funds are holding shares in FEMY
---
Femasys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.00 (547.48% Upside)
$9.00 (547.48% Upside)
Blogger Sentiment
Bullish
FEMY Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.9%
Last 30 Days ▼ 5.2%
Last 30 Days ▼ 5.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.92%
12-Months-Change
Fundamentals
Return on Equity
-84.82%
Trailing 12-Months
Asset Growth
64.28%
Trailing 12-Months
Company Description
Femasys
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. Its mission is to provide women with minimally-invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics.
---
FEMY Stock 12 Month Forecast
Average Price Target
$9.00
▲(547.48% Upside)
Technical Analysis
Best Analysts Covering FEMY
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
+49.37%
reiterated a buy rating 6 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +49.37% per trade.
---